V. Wee Yong, Ph.D.

Affiliations: 
Departments of Clinical Neurosciences and Oncology University of Calgary, Calgary, Alberta, Canada 
Area:
Multiple Sclerosis
Website:
http://www.vweeyong.com/wee_bio.htm
Google:
"https://www.google.ca/search?q=voon+wee+yong&oq=voon+&aqs=chrome.1.69i57j0l5.3423j0j7&sourceid=chrome&espv=210&es_sm=119&ie=UTF-8"
Bio:

Dr. V. Wee Yong is a Professor at the Hotchkiss Brain Institute and the Departments of Clinical Neurosciences and Oncology at The University of Calgary. He co-directs the Multiple Sclerosis (MS) Program of the Hotchkiss Brain Institute and he holds the Canada Research Chair in Neuroimmunology. Dr. Yong’s research interests lie in the area of neuroimmunology, neuroprotection and CNS regeneration, and his projects have been guided by MS, spinal cord injury and malignant gliomas. Dr. Yong has published 208 peer-reviewed manuscripts and his research has been translated into clinical trials, including Phase III trials, in MS and spinal cord injury. His work has been cited over 12,000 times by other authors in scientific publications. Dr. Yong’s lecture invitations are in the areas of matrix metalloproteinases, minocycline, remyelination and multiple areas of MS including mechanisms of MS medications, environmental factors and repair. Dr. Yong has strong commitments to the patient and trainee communities; he has been awarded the Queen’s Golden Jubilee Year Medallion for volunteer activities on behalf of the MS Society of Canada, and he directs the Alberta endMS Regional Research and Training Center of over 150 trainees. Dr. Yong is the immediate past chair of the Medical Advisory Committee of the MS Society of Canada, and he is on the editorial board of 7 international journals. Dr. Yong was recently elected by an international community to be the Vice-President of the International Society of Neuroimmunology from November 2012; he will become the President in 2014.
(Show less)

Mean distance: 17.18 (cluster 11)
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Bhattacharya A, Kaushik DK, Lozinski BM, et al. (2020) Beyond barrier functions: Roles of pericytes in homeostasis and regulation of neuroinflammation. Journal of Neuroscience Research
Pu A, Mishra MK, Dong Y, et al. (2020) The glycosyltransferase EXTL2 promotes proteoglycan deposition and injurious neuroinflammation following demyelination. Journal of Neuroinflammation. 17: 220
Sarkar S, Yang R, Mirzaei R, et al. (2020) Control of brain tumor growth by reactivating myeloid cells with niacin. Science Translational Medicine. 12
Rawji KS, Young AMH, Ghosh T, et al. (2020) Correction to: Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system. Acta Neuropathologica
Sarkar S, Li Y, Mirzaei R, et al. (2020) Demeclocycline Reduces the Growth of Human Brain Tumor-Initiating Cells: Direct Activity and Through Monocytes. Frontiers in Immunology. 11: 272
Rawji KS, Young AMH, Ghosh T, et al. (2020) Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system. Acta Neuropathologica
Plemel JR, Stratton JA, Michaels NJ, et al. (2020) Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion. Science Advances. 6: eaay6324
Bai Q, Xue M, Yong VW. (2020) Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities. Brain : a Journal of Neurology
Feliu A, Mestre L, Carrillo-Salinas FJ, et al. (2020) 2-arachidonoylglycerol reduces chondroitin sulphate proteoglycan production by astrocytes and enhances oligodendrocyte differentiation under inhibitory conditions. Glia. 68: 1255-1273
Dong Y, Yong VW. (2019) When encephalitogenic T cells collaborate with microglia in multiple sclerosis. Nature Reviews. Neurology
See more...